Variations in the Design and Use of Attention Control Groups in Type 2 Diabetes Randomized Controlled Trials: a Systematic Review.

IF 5.2 2区医学 Q1 ENDOCRINOLOGY & METABOLISM

Current Diabetes Reports Pub Date : 2023-09-01 Epub Date: 2023-06-09 DOI:10.1007/s11892-023-01514-2

Casey A Droske, Triniece N Pearson, Sharon J Velkovich, Hannah Cohn, Jacqueline M Kanoon, Arshiya A Baig, Valerie G Press

{"title":"Variations in the Design and Use of Attention Control Groups in Type 2 Diabetes Randomized Controlled Trials: a Systematic Review.","authors":"Casey A Droske, Triniece N Pearson, Sharon J Velkovich, Hannah Cohn, Jacqueline M Kanoon, Arshiya A Baig, Valerie G Press","doi":"10.1007/s11892-023-01514-2","DOIUrl":null,"url":null,"abstract":"Purpose of review: In type 2 diabetes (T2D) research, the phrase \"attention control group\" (ACGs) has been used with varying descriptions. We aimed to systematically review the variations in the design and use of ACGs for T2D studies.Recent findings: Twenty studies utilizing ACGs were included in the final evaluation. Control group activities had the potential to influence the primary outcome of the study in 13 of the 20 articles. Prevention of contamination across groups was not mentioned in 45% of the articles. Eighty-five percent of articles met or somewhat met the criteria for having comparable activities between the ACG and intervention arms. Wide variations in descriptions and the lack of standardization have led to an inaccurate use of the phrase \"ACGs\" when describing the control arm of trials, indicating a need for future research with focus on the adoption of uniform guidelines for use of ACGs in T2D RCTs.","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"23 9","pages":"217-229"},"PeriodicalIF":5.2000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527690/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Diabetes Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11892-023-01514-2","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/9 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: In type 2 diabetes (T2D) research, the phrase "attention control group" (ACGs) has been used with varying descriptions. We aimed to systematically review the variations in the design and use of ACGs for T2D studies.

Recent findings: Twenty studies utilizing ACGs were included in the final evaluation. Control group activities had the potential to influence the primary outcome of the study in 13 of the 20 articles. Prevention of contamination across groups was not mentioned in 45% of the articles. Eighty-five percent of articles met or somewhat met the criteria for having comparable activities between the ACG and intervention arms. Wide variations in descriptions and the lack of standardization have led to an inaccurate use of the phrase "ACGs" when describing the control arm of trials, indicating a need for future research with focus on the adoption of uniform guidelines for use of ACGs in T2D RCTs.

Abstract Image

查看原文本刊更多论文

2型糖尿病随机对照试验中注意力控制组设计和使用的变化：系统综述。

综述目的：在2型糖尿病（T2D）研究中，“注意力控制组”（ACGs）一词的使用有不同的描述。我们旨在系统地回顾T2D研究中ACG设计和使用的变化。最近的发现：20项利用ACG的研究被纳入最终评估。在20篇文章中的13篇文章中，对照组的活动有可能影响研究的主要结果。45%的文章中没有提到预防跨组污染。85%的文章符合或在一定程度上符合ACG和干预部门之间具有可比活动的标准。描述的广泛差异和缺乏标准化导致在描述试验的对照组时使用“ACG”一词不准确，这表明未来需要进行研究，重点是采用T2D随机对照试验中ACG使用的统一指南。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Diabetes Reports 医学 -

CiteScore

9.80

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： The goal of this journal is to publish cutting-edge reviews on subjects pertinent to all aspects of diabetes epidemiology, pathophysiology, and management. We aim to provide incisive, insightful, and balanced contributions from leading experts in each relevant domain that will be of immediate interest to a wide readership of clinicians, basic scientists, and translational investigators. We accomplish this aim by appointing major authorities to serve as Section Editors in key subject areas across the discipline. Section Editors select topics to be reviewed by leading experts who emphasize recent developments and highlight important papers published over the past year on their topics, in a crisp and readable format. We also provide commentaries from well-known figures in the field, and an Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research.